Show
Sort by
-
Noninvasive monitoring of therapy-induced microvascular changes in a pancreatic cancer model using dynamic contrast-enhanced magnetic resonance imaging with P846, a new low-diffusible gadolinium-based contrast agent
-
EGFR in melanoma : clinical significance and potential therapeutic target
-
Diffusion magnetic resonance imaging as surrogate marker to anti-VEGF treatment response in MCTC
-
PET evaluation of anti-VEGF treatment in combination with chemotherapy in MCRC
-
Comparison of two contrast agents for DCE-MRI evaluation of anti-VEGF treatment in combination with chemotherapy in MCRC
-
FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases
-
Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors
-
In vitro cytotoxicity of paclitaxel/β-cyclodextrin complexes for HIPEC
-
Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: a prospective dose finding phase I-II study
-
Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis